The “irAE info” application is intended for practitioners who use immune checkpoint inhibitors (nivolumab, ipilimumab) in their practice for malignant neoplasms in adults.
“IrAE info” contains background information on immune-mediated adverse events inherent in these drugs.
Application design can make it easier and faster for a doctor to access this information.
“IrAE info” contains background information on immune-mediated adverse events inherent in these drugs.
Application design can make it easier and faster for a doctor to access this information.
Show More
